Shuttle Pharmaceuticals ...
0.86
-0.02 (-1.85%)
At close: Jan 15, 2025, 1:21 PM

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY18 FY17
PE Ratio -8.78 -52.37 -3.48K -4.95K -6.68K -19.58K
PS Ratio n/a n/a n/a n/a n/a n/a
PB Ratio 14.28 21.14 -2.57K -2.47K 152.33K -14.71K
P/FCF Ratio -10.34 -59.88 -13.93K -111.09K -7.38K -20.63K
P/OCF Ratio -10.37 -59.88 -13.93K -155.88K -7.38K -20.63K
OCF/S Ratio n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio 0.27 0.10 -0.6 -0.48 14.57 -1.11
Quick Ratio 5.37 8.79 0.23 0.16 1.03 0.25
Current Ratio 5.37 8.79 0.23 0.16 1.03 0.25
Asset Turnover n/a n/a n/a n/a n/a n/a
Interest Coverage -2.27 -2.63 -34.32 -12.86 -18.97 -18.74
Return on Equity (ROE) -1.63 -0.4 0.74 0.50 -22.81 0.75
Return on Assets (ROA) -1.11 -0.36 -1.85 -1.55 -1.01 -1.76
Return on Capital (ROIC) -1.2 -0.33 1.11 0.33 -21.37 0.72
Dividend Yield n/a 0.00 n/a n/a n/a n/a
Payout Ratio n/a -0.13 n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a n/a